Abstract
The syndrome of intracranial hypertension without structural brain or cerebrospinal fluid abnormalities and without identifiable cause, now most appropriately termed idiopathic intracranial hypertension, was described over a century ago. Although the pathogenesis of this condition remains unknown, diagnostic and therapeutic developments during the past two decades have substantially advanced patient management.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Carbonic Anhydrase Inhibitors / therapeutic use
-
Cerebrospinal Fluid Shunts
-
Decompression, Surgical
-
Diet Therapy
-
Diuretics / therapeutic use
-
Humans
-
Optic Nerve / surgery
-
Prognosis
-
Pseudotumor Cerebri / diagnosis*
-
Pseudotumor Cerebri / physiopathology
-
Pseudotumor Cerebri / therapy*
-
Spinal Puncture
-
Vision, Ocular
Substances
-
Adrenal Cortex Hormones
-
Carbonic Anhydrase Inhibitors
-
Diuretics